Levosin CR Extended-Release Tablets (Levodropropizine)

Adult dose

Adults: Take 1 tablet (equivalent to 90mg of levodropropizine) orally twice daily. This is an extended-release formulation; swallow it whole without splitting or crushing.

This medication should not be used in patients who have had an allergic reaction to it or any of its components. It is also not safe to administer to patients with increased bronchial mucus secretion or impaired ciliary function. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication. Patients with severe liver impairment should also avoid using this drug. Since this medication contains lactose, it should be avoided by those with lactose intolerance or related genetic disorders. Caution is necessary when administering it to patients with severely impaired heart or kidney function, elderly patients, and children. This medication may cause neurological symptoms such as drowsiness, headache, or dizziness; therefore, caution should be exercised when driving or operating machinery. Especially, taking it with alcohol may worsen these symptoms. Since it is an extended-release formulation, it is better to use other forms for children. Caution is needed when taken with sedatives, as the effects of the medication may be intensified. During the use of this medication, there may be occurrences of allergic reactions or gastrointestinal symptoms, so consult a doctor immediately if any unusual symptoms appear. This drug should be stored out of the reach of children, and transferring it to another container should be avoided as it may affect its quality.

• Nausea
• indigestion
• constipation
• drowsiness
• headache
• dizziness
• postural vertigo
• eyelid swelling
• increased leukocytes in urine
• elevated ALT

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. The storage temperature should be maintained at room temperature between 1 to 30 degrees Celsius. This helps to maintain the medication's effectiveness and safety over time.

Appearance

An elongated extended-release tablet consisting of a white to pale yellow upper layer and a white lower layer.

Package unit

30 tablets/bottle, 300 tablets/bottle